Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

News Focus

Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)

Bullboard - Stock Discussion Forum Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Healthcare

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the... see more

Add To Watchlist

Bullboard (NDAQ:LEXX)

View:

Comment by lscfaon Jan 24, 2024 1:23pm

RE:LEXX.....Go read the President 's msg to Sh Holders

Excerpt: The pharmaceutical industry values drug delivery technology more wholesomely than does the CPG industry. This is apparent in the 2020/21 transaction whereby Novo Nordisk paid ...more

Discussion

Post by Iseneschalon Jan 24, 2024 12:27pm

LEXX.....Go read the President 's msg to Sh Holders

Normally ...I'm pretty hard on Directors.....but this guy just told it like it was ! Seriously...Mr. Bunka did an honorable job with that....go read the whole letter. Lexaria Releases ...more

136

Discussion

NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets

posted Nov 14, 2024 9:00am by NurExone Biologic Inc.

“We are honored by the EMA’s recognition of ExoPTEN through the Orphan Medicinal Product Designation, which significantly advances our ability to enter the European market and offers hope to those impacted by acute spinal cord injuries,” said Dr. Lior Shaltiel, Chief Executive Officer of NurExone. “This designation, together with the ...read more

Comment by lscfaon Jan 04, 2024 11:43am

RE:Lexx Tech Improves Performance of oral GLP-1 drug

Final results.... https://www.thenewswire.com/press-releases/1A0vFGJxa-lexaria-s-patented-technology-improved-the-oral-performance-of-the-rybelsus-branded-glp-1-drug-semaglutide.html

Discussion

Post by lscfaon Dec 23, 2023 10:17am

$10 US TP

https://s27.q4cdn.com/906368049/files/News/2023/Zacks_SCR_Research_11302023_LEXX_Vandermosten.pdf

101

Post by Yowza123on Nov 28, 2023 9:22am

LEXX lowers blood glucose more effectively than Rybelsus

https://ir.lexariabioscience.com/news-events/press-releases/detail/230/lexarias-technology-lowers-blood-glucose-more-effectively

Post by lscfaon Nov 27, 2023 11:55am

Lexx Tech Improves Performance of oral GLP-1 drug

https://www.thenewswire.com/press-releases/1Bz4FN7bO-lexarias-technology-improves-the-oral-performance-of-the-rybelsus-branded-glp-1-drug-semaglutide-in-human-pilot-study.html

Discussion

Comment by ranmanon Nov 23, 2023 5:12pm

RE:RE:Lexaria Bioscience Corp. (NASDAQ: LEXX) - A Zacks Update

Should do better than $12.00 if the new wt loss drug can make it into our stable of pharmaceuticals. Novo Nordisk shares rise as Wegovy shows heart benefits beyond weight loss weight control

Discussion

Post by ranmanon Oct 13, 2023 12:50pm

Why this is a great step .

Lexaria Enters New Global Exclusive Collaboration and License Agreement with SulfoSyn ...more

172

Post by ranmanon Oct 13, 2023 12:46pm

Why this is a great step .

Lexaria Enters New Global Exclusive Collaboration and License Agreement with SulfoSyn What is Sulforaphane? Plants have compounds that they employ to defend themselves. These compounds are ...more

170